image
Sangamo Therapeutics, Inc. SGMO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.05
-4.65 %
$ 428 M
Market Cap
-1.68
P/E
INCOME STATEMENT
176 M REVENUE
58.34%
Growth Rates
1Year 58.34%
3Years 14.24%
5Years 15.85%
7Years 37.07%
10Years 22.00%
-274 M OPERATING INCOME
-36.13%
Growth Rates
1Year -36.13%
3Years -28.36%
5Years -28.85%
7Years -20.90%
10Years -26.22%
-258 M NET INCOME
-34.09%
Growth Rates
1Year -34.09%
3Years -28.64%
5Years -30.21%
7Years -20.07%
10Years -25.49%
EFFICIENCY
Earnings Waterfall Sangamo Therapeutics, Inc.
image
Revenue 176 M
Cost Of Revenue 222 M
Gross Profit -45.3 M
Operating Expenses 229 M
Operating Income -274 M
Other Expenses -16.2 M
Net Income -258 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
REVENUE
Revenue 176.2 111.3 110.7 118.2 102.4 84.5 36.6 19.4 39.5 45.9 24.1 21.7 10.3 20.8 22.2 16.2 9.1 7.9 2.5 1.3 2.6 4.3 4.9 3.4 2.2 2.0 1.2 0.6
GROSS PROFIT
Cost Of Revenue 221.6 12.1 9.4 180.6 145.9 114.9 65.7 65.6 67.1 56.7 37.0 31.7 0 0 0 0 0 0 0 0 0 0 0 (5.2) (0.7) 0 0 0
Gross Profit (45.3) 99.2 101.3 (62.5) (43.5) (30.4) (29.2) (46.2) (27.6) (10.9) (12.8) (10.1) 10.3 20.8 22.2 16.2 9.1 7.9 2.5 1.3 2.6 4.3 4.9 8.7 2.9 2.0 1.2 0.6
OPERATING INCOME
Operating Expenses 228.7 312.6 294.0 247.7 207.6 161.6 92.9 91.9 86.4 72.4 50.8 43.9 46.1 45.7 41.6 41.6 33.9 28.6 16.2 16.0 14.3 35.5 20.3 21.1 6.8 5.5 2.5 0.9
Selling, General and Administrative Expenses 61.2 62.7 63.2 67.1 61.7 46.7 27.2 26.3 19.2 15.7 13.8 12.1 14.0 12.6 12.6 10.3 8.3 7.1 4.5 4.9 3.6 4.2 4.8 4.6 1.8 1.2 0.8 0.3
Research and Development Expenses 234.1 249.9 230.8 180.6 145.9 114.9 65.7 65.6 67.2 56.7 37.0 31.7 32.1 33.2 29.0 31.2 25.6 21.5 11.4 11.0 10.2 13.4 15.5 11.3 4.3 4.3 1.7 0.6
Operating Income (274.0) (201.3) (183.3) (129.6) (105.2) (77.2) (56.4) (72.6) (46.9) (26.8) (26.7) (22.2) (35.8) (24.9) (19.4) (25.4) (24.8) (20.7) (13.7) (14.7) (11.8) (31.6) (28.4) (12.5) (3.9) (3.5) (1.3) (0.3)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0
Total Other Income 11.1 9.4 5.3 8.8 9.8 8.3 1.8 0.9 0.4 0.4 82 K 66 K 71 K 81 K 0.8 1.1 3.3 2.9 0.5 0.8 1.3 1.8 3.2 0 0 3.5 1.3 0.3
Pre-Tax Income (262.9) (191.8) (178.0) (120.8) (95.4) (68.9) (54.6) (71.7) (46.4) (26.4) (26.6) (22.3) (35.8) (24.9) (18.6) (24.3) (21.5) (17.9) (13.3) (13.8) (10.4) (29.8) (25.2) 0 0 0 0 0
NET INCOME
Tax Provision (5.1) 0.4 0.3 0.3 (19.6) 8.3 (1.5) 14 K (5.7) (0.7) (0.6) (0.7) (0.6) (0.7) (0.8) (1.1) (1.4) (2.2) (0.5) (0.8) (1.3) (1.4) 9.9 (3.4) 100 K 3.3 1.4 0.3
Net Income (257.8) (192.3) (178.3) (121.1) (75.8) (68.3) (54.6) (71.7) (40.7) (26.4) (26.6) (22.3) (35.8) (24.9) (18.6) (24.3) (21.5) (17.9) (13.3) (13.8) (10.4) (29.8) (25.2) (9.1) (3.8) (3.3) (1.4) (0.3)
EPS 1.48 1.25 1.23 0.9 0.68 0.7 0.7 1.02 0.58 0.39 0.48 0.42 0.71 0.55 0.44 0.6 0.58 0.55 0.51 0.55 0.42 1.22 1.09 0.52 0.63 0.56 0.26 0.0599